J 2003

Prolactin levels in risperidone treatment of first episode schizophrenia.

ČEŠKOVÁ, Eva, Radovan PŘIKRYL, Tomáš KAŠPÁREK a Marta ONDRUŠOVÁ

Základní údaje

Originální název

Prolactin levels in risperidone treatment of first episode schizophrenia.

Název anglicky

Prolactin levels in risperidone treatment of first episode schizophrenia.

Autoři

ČEŠKOVÁ, Eva (203 Česká republika, garant), Radovan PŘIKRYL (203 Česká republika), Tomáš KAŠPÁREK (203 Česká republika) a Marta ONDRUŠOVÁ (203 Česká republika)

Vydání

International Journal of Psychiatry in Clinical Practice, 2003, 1365-1501

Další údaje

Jazyk

čeština

Typ výsledku

Článek v odborném periodiku

Obor

30000 3. Medical and Health Sciences

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 0.191

Kód RIV

RIV/00216224:14110/03:00021237

Organizační jednotka

Lékařská fakulta

UT WoS

000220242100006

Klíčová slova anglicky

prolactin; risperidone; schizophrenia

Štítky

Změněno: 23. 6. 2009 11:23, prof. MUDr. Eva Češková, CSc.

Anotace

ORIG EN

V originále

Patients with a first-episode of schizophrenia were clinical evaluated by PANSS and prolactinemia was assesed. Patients were treated with risperidon. Risperidon in average dose lower than 4 mg significantly improved both positive and negative symptoms. At the end of acute treatment the average elevation of PRL levels almost doubled the baseline value.There was a trend among responders to return to their initial values during long-term therapy.

Anglicky

Patients with a first-episode of schizophrenia were clinical evaluated by PANSS and prolactinemia was assesed. Patients were treated with risperidon. Risperidon in average dose lower than 4 mg significantly improved both positive and negative symptoms. At the end of acute treatment the average elevation of PRL levels almost doubled the baseline value.There was a trend among responders to return to their initial values during long-term therapy.